To test or not? Xpert MTB/RIF as an alternative to smear microscopy to guide line probe assay testing for drug-resistant tuberculosis is a research paper published in medRxiv (2022). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European & Developing Countries Clinical Trials Partnership (EDCTP)
Grant: RIA2020I-3305
European & Developing Countries Clinical Trials Partnership (EDCTP)
Grant: RIA2018D-2493
European & Developing Countries Clinical Trials Partnership (EDCTP)
Grant: RIA2018D-2509